PhD Robert Roškar

PhD Robert Roškar
no.: 23549 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
  • German
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Drug stability, instrumental analysis in pharmacy
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
1,486.17
A''
223.12
A'
905.77
A1/2
1,250.3
CI10
1,086
CImax
143
h10
17
A1
5.54
A3
2.26
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 79  1,238  1,110  14.05 
Scopus 82  1,380  1,252  15.27 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair of Pharmaceutical Technology 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J2-60047  Magnetic micro-structuring of the Mg alloy surfaces for improved endothelialization and retained degradability of vascular stent materials   1/1/2025 - 12/31/2027  PhD Slavko Kralj   3,445 
2. J7-4418  Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections   10/1/2022 - 9/30/2025  PhD Špela Zupančič   5,917 
3. J2-4480  Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma)   10/1/2022 - 9/30/2025  PhD Martin Petkovšek   3,135 
4. J2-3043  Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases   10/1/2021 - 9/30/2025  PhD Slavko Kralj   4,787 
5. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   10/1/2021 - 9/30/2024  PhD Iztok Grabnar   3,178 
6. J1-9194  Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease   7/1/2018 - 6/30/2022  PhD Julijana Kristl   3,691 
7. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   3/1/2016 - 2/28/2019  PhD Igor Emri   4,681 
8. J1-6744  Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene)   7/1/2014 - 6/30/2017  PhD Tina Kosjek   5,213 
9. J3-4220  Vloga genetskih polimorfizmov na izid zdravljenja in pojav zapletov pri otrocih z rakom (Slovene)   7/1/2011 - 6/30/2014  PhD Janez Jazbec   3,655 
10. J3-4313  Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene)   7/1/2011 - 6/30/2014  PhD Albin Kristl   3,298 
11. J3-3615  Farmakogenetski pristop k raziskavam, diagnostiki in terapiji levkemij (Slovene)   5/1/2010 - 4/30/2013  PhD Irena Mlinarič Raščan   2,282 
12. J3-2330  Genetski dejavniki pri osteoporozi (Slovene)   5/1/2009 - 4/30/2012  PhD Janja Marc   2,480 
13. J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)   5/1/2009 - 4/30/2012  PhD Nada Kraševec   3,901 
14. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport   2/1/2008 - 1/30/2011  PhD Aleš Mrhar   2,034 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0189  Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly   1/1/2018 - 12/31/2027 PhD Mitja Kos   7,244 
2. P1-0189  Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly   1/1/2014 - 12/31/2017 PhD Albin Kristl   7,163 
3. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2009 - 12/31/2014 PhD Danijel Kikelj   6,386 
4. P1-0189  Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih (Slovene)   1/1/2009 - 12/31/2013 PhD Aleš Mrhar   7,268 
5. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2004 - 12/31/2008 PhD Danijel Kikelj   6,446 
International projects
no. Code Title Period Head
1. CELSA - Cental Europe Leuven Strategic Alliance-Generiranje nanoteles...  Generation of nanobodies against immunomodulating checkpoint receptors in glioblastoma tumor cells   10/1/2020 - 9/30/2022 PhD Ivana Jovchevska    
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite